SCHANN; Stephan

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHANN; Stephan.The latest application filed is for "5-heteroaryl-pyridin-2-amine compounds as neuropeptide ff receptor antagonists".

Company Profile

4.9.14

SCHANN; Stephan - Illkirch-Graffenstaden FR
SCHANN; Stephan - IIIkirch-Graffenstaden FR
SCHANN; Stephan - Illkirch FR
Schann; Stephan - Graffenstaden N/A FR
Schann; Stephan - Geispolsheim FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
5-heteroaryl-pyridin-2-amine Compounds As Neuropeptide Ff Receptor Antagonists App 20220298135 - SCHANN; Stephan ; et al.	2022-09-22
Substituted Quinazolinone Derivatives And Their Use As Positive Allosteric Modulators Of Mglur4 App 20220089609 - AMALRIC; Camille ; et al.	2022-03-24
5-azaindazole Derivatives As Adenosine Receptor Antagonists App 20210380606 - BLAYO; Anne-Laure ; et al.	2021-12-09
Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors Grant 11,008,323 - Schann , et al. May 18, 2	2021-05-18
Substituted Heterocyclic Compounds As Allosteric Modulators Of Group Ii Metabotropic Glutamate Receptors App 20200140438 - BLAYO; Anne-Laure ; et al.	2020-05-07
Substituted Pyrazoloquinazolinones And Pyrroloquinazolinones As Allosteric Modulators Of Group Ii Metabotropic Glutamate Recepto App 20190152979 - SCHANN; Stephan ; et al.	2019-05-23
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors Grant 10,221,179 - Schann , et al.	2019-03-05
Substituted Tricyclic 1,4-benzodiazepinone Derivatives As Allosteric Modulators Of Group Ii Metabotropic Glutamate Receptors App 20180346468 - SCHANN; Stephan ; et al.	2018-12-06
Substituted Pyrazoloquinazolinones And Pyrroloquinazolinones As Allosteric Modulators Of Group Ii Metabotropic Glutamate Receptors App 20170305913 - SCHANN; Stephan ; et al.	2017-10-26
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors Grant 9,434,734 - Mayer , et al. September 6, 2	2016-09-06
Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome Grant 9,303,019 - Bousquet , et al. April 5, 2	2016-04-05
Adenosine receptor ligands and uses thereof Grant 9,029,393 - Schann , et al. May 12, 2	2015-05-12
Substituted Pyrazoloquinazolinones And Pyrroloquinazolinones As Allosteric Modulators Of Group Ii Metabotropic Glutamate Receptors App 20150105381 - Mayer; Stanislas ; et al.	2015-04-16
Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors Grant 8,962,627 - Schann , et al. February 24, 2	2015-02-24
Novel Amino-pyrroline Derivatives, And Use Thereof In The Prevention And/or Treatment Of Metabolic Syndrome App 20140045910 - Bousquet; Pascal ; et al.	2014-02-13
Novel Oxime Derivatives and Their Use As Allosteric Modulators of Metabotropic Glutamate Receptors App 20120277212 - Schann; Stephan ; et al.	2012-11-01
New Adenosine Receptor Ligands And Uses Thereof App 20110288074 - Schann; Stephan ; et al.	2011-11-24
Pyrrolo[1,2-a]quinoxaline Derivatives As Adenosine A3 Receptor Modulators And Uses Thereof App 20090093476 - Schann; Stephan ; et al.	2009-04-09
Trans Pyrrolidinyl Derivates and Their Pharmaceutical Use App 20080027127 - Schann; Stephan ; et al.	2008-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.